Report Detail

Request for Sample of this report

Other Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size, Status and Forecast 2021-2027

  • RnM2690917
    • |
  • 19 January, 2021
    • |
  • Global
    • |
  • 98 Pages
    • |
  • QYResearch
    • |
  • Other

Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Therapy
Injectable Therapy

Segment by Application
Hospitals & Clinics
Home Settings
Ambulatory Surgical Centers (ASCs)

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Astellas Inc.
Johnson & Johnson
Sanofi S.A
Dendreon Corporation
Bayer AG
Dendreon Corporation


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Oral Therapy
    • 1.2.3 Injectable Therapy
  • 1.3 Market by Application
    • 1.3.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals & Clinics
    • 1.3.3 Home Settings
    • 1.3.4 Ambulatory Surgical Centers (ASCs)
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Perspective (2016-2027)
  • 2.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Growth Trends by Regions
    • 2.2.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Historic Market Share by Regions (2016-2021)
    • 2.2.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecasted Market Size by Regions (2022-2027)
  • 2.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Industry Dynamic
    • 2.3.1 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Trends
    • 2.3.2 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Drivers
    • 2.3.3 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Challenges
    • 2.3.4 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Players by Revenue
    • 3.1.1 Global Top Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Players by Revenue (2016-2021)
    • 3.1.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue Market Share by Players (2016-2021)
  • 3.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue
  • 3.4 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Concentration Ratio
    • 3.4.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Revenue in 2020
  • 3.5 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Key Players Head office and Area Served
  • 3.6 Key Players Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Product Solution and Service
  • 3.7 Date of Enter into Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Breakdown Data by Type

  • 4.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Historic Market Size by Type (2016-2021)
  • 4.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecasted Market Size by Type (2022-2027)

5 Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Breakdown Data by Application

  • 5.1 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Historic Market Size by Application (2016-2021)
  • 5.2 Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2016-2027)
  • 6.2 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
    • 6.2.1 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2016-2021)
    • 6.2.2 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2022-2027)
    • 6.2.3 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2016-2027)
  • 6.3 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
    • 6.3.1 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2016-2021)
    • 6.3.2 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2022-2027)
    • 6.3.3 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2016-2027)
  • 6.4 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country
    • 6.4.1 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (2016-2021)
    • 6.4.2 North America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2016-2027)
  • 7.2 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
    • 7.2.1 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2016-2021)
    • 7.2.2 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2022-2027)
    • 7.2.3 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2016-2027)
  • 7.3 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
    • 7.3.1 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2016-2021)
    • 7.3.2 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2022-2027)
    • 7.3.3 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2016-2027)
  • 7.4 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country
    • 7.4.1 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (2016-2021)
    • 7.4.2 Europe Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2016-2027)
  • 8.2 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
    • 8.2.1 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
    • 8.3.1 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Region
    • 8.4.1 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2016-2027)
  • 9.2 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
    • 9.2.1 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2016-2021)
    • 9.2.2 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2022-2027)
    • 9.2.3 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2016-2027)
  • 9.3 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
    • 9.3.1 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2016-2021)
    • 9.3.2 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2022-2027)
    • 9.3.3 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2016-2027)
  • 9.4 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country
    • 9.4.1 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (2016-2021)
    • 9.4.2 Latin America Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size (2016-2027)
  • 10.2 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type
    • 10.2.1 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application
    • 10.3.1 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country
    • 10.4.1 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Astellas Inc.
    • 11.1.1 Astellas Inc. Company Details
    • 11.1.2 Astellas Inc. Business Overview
    • 11.1.3 Astellas Inc. Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
    • 11.1.4 Astellas Inc. Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2016-2021)
    • 11.1.5 Astellas Inc. Recent Development
  • 11.2 Johnson & Johnson
    • 11.2.1 Johnson & Johnson Company Details
    • 11.2.2 Johnson & Johnson Business Overview
    • 11.2.3 Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
    • 11.2.4 Johnson & Johnson Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2016-2021)
    • 11.2.5 Johnson & Johnson Recent Development
  • 11.3 Sanofi S.A
    • 11.3.1 Sanofi S.A Company Details
    • 11.3.2 Sanofi S.A Business Overview
    • 11.3.3 Sanofi S.A Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
    • 11.3.4 Sanofi S.A Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2016-2021)
    • 11.3.5 Sanofi S.A Recent Development
  • 11.4 Dendreon Corporation
    • 11.4.1 Dendreon Corporation Company Details
    • 11.4.2 Dendreon Corporation Business Overview
    • 11.4.3 Dendreon Corporation Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
    • 11.4.4 Dendreon Corporation Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2016-2021)
    • 11.4.5 Dendreon Corporation Recent Development
  • 11.5 Bayer AG
    • 11.5.1 Bayer AG Company Details
    • 11.5.2 Bayer AG Business Overview
    • 11.5.3 Bayer AG Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Introduction
    • 11.5.4 Bayer AG Revenue in Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Business (2016-2021)
    • 11.5.5 Bayer AG Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics . Industry analysis & Market Report on Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics is a syndicated market report, published as Global Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,900.00
    		$5,850.00
    		$7,800.00
    		3,108.30
    		4,662.45
    		6,216.60
    		3,623.10
    		5,434.65
    		7,246.20
    		596,427.00
    		894,640.50
    		1,192,854.00
    		325,338.00
    		488,007.00
    		650,676.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo